Cambridge Investment Research Advisors
GEN

Cambridge Investment Research Advisors’s Genesis Healthcare, Inc. GEN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-14,500
Closed -$17K – 2182
2017
Q3 		$17K Buy
+14,500
New +$18.3K ﹤0.01% 1984
2017
Q2 		– Sell
-91,802
Closed -$242K – 1997
2017
Q1 		$242K Buy
91,802
+81,480
+789% +$293K ﹤0.01% 1513
2016
Q4 		$44K Buy
+10,322
New +$34K ﹤0.01% 1629

Other funds holding GEN

CPA
Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cambridge Investment Research Advisors's GEN Position: Q4 2017 in Review

Cambridge Investment Research Advisors sold out of Genesis Healthcare, Inc. (GEN) in Q4 2017, closing a stake of 14,500 shares — an estimated $17K sold.

Cambridge Investment Research Advisors first reported a position in GEN in Q4 2016 and held it in 3 quarters. The position peaked at $242K in Q1 2017. 68 funds tracked by Wall St. Rank hold GEN as of Q4 2017.

  • Cambridge Investment Research Advisors reported no remaining Genesis Healthcare, Inc. position as of Q4 2017 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 14,500 Genesis Healthcare, Inc. shares in Q4 2017, an estimated $17K.
  • Cambridge Investment Research Advisors first reported a position in Genesis Healthcare, Inc. in Q4 2016 and held it in 3 quarters.
  • Cambridge Investment Research Advisors's Genesis Healthcare, Inc. position peaked at $242K in Q1 2017.
  • 68 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2017.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2017, filed 22 Feb 2018.